Skip to content

AI-Powered Forecasts for Biotech Investors

  • Home
  • Tools
    • Predictions
    • Scores
    • News Stream
    • Launch Probe
  • About
    • Why Biotech?
    • XBI Overview
    • Pricing
    • How ScanScor Stands Apart
    • Terms and Conditions
  • Join ScanScor
    • Membership Account
    • Your Profile
    • Membership Billing
  • Log In
EagleTrader ScanScor
EagleTrader ScanScor

Predicting Clinical Breakouts using AI

EagleTrader ScanScor
EagleTrader ScanScor

Predicting Clinical Breakouts using AI

  • About
  • AI Stock Report Archive
  • BioMed Prediction Engine (BPE) Reports
  • BPE News Stream
  • Home
  • How the BPE (BioMed Prediction Engine) Works
  • Join the ScanScor Revolution
  • Log In
  • Membership Account
    • Membership Billing
    • Membership Cancel
    • Membership Orders
    • Your Profile
  • Membership Checkout
    • Membership Confirmation
  • Past AI Winners
  • Prediction Scores
  • Pricing
  • ScanScor Price Leaders
  • Terms and Conditions
  • Why Biotech?
  • XBI Overview

Author name: Tony Fogleman

AI Biomed Predictions

SGMO – Sangamo Poised for Breakout with Forthcoming BLA Submission

Tony Fogleman / July 3, 2025
AI Biomed Predictions

GALT – Promising Trial Results Could Propel Galectin Therapeutics

Tony Fogleman / July 3, 2025
AI Biomed Predictions

OMER – Omeros Set for Potential Breakout Ahead of FDA Decision

Tony Fogleman / July 3, 2025
AI Biomed Predictions

CRMD – CorMedix Set for Breakout with DefenCath’s Outpatient Launch

Tony Fogleman / July 3, 2025
AI Biomed Predictions

LXRX – Lexicon Pharmaceuticals Set for Breakout Amidst Clinical Advances

Tony Fogleman / July 3, 2025
AI Stock Report

BLMZ – bloomz-faces-steep-challenges-amidst-drastic-market-decline

Tony Fogleman / May 6, 2025
AI Stock Report

MRIN – marin-software-battles-severe-financial-downturn-amid-market-challenges

Tony Fogleman / May 6, 2025
AI Stock Report

FOXO – foxo-technologies-volatility-amidst-financial-turmoil

Tony Fogleman / May 6, 2025
AI Stock Report

SST – system1-faces-volatility-amid-high-insider-ownership-and-losses

Tony Fogleman / May 6, 2025
AI Stock Report

RCKY – rocky-brands-mixed-signals-amid-growth-and-challenges

Tony Fogleman / May 6, 2025
← Previous 1 … 12 13 14 … 142 Next →

Tools

  • Predictions
  • Prediction Scores
  • BPE News Stream
  • Build and Launch Probe

Recent Comments

  1. Tony Fogleman on BTAI – Anticipating Breakout: BioXcel’s SERENITY Trial Could Revolutionize Treatment
  2. Tony Fogleman on FGEN – FibroGen Poised for Recovery with Key Trial Updates
  3. Tony Fogleman on GEVO – Gevo Set for Breakout as Green Fuel Innovations Gain Traction
  4. Tony Fogleman on QURE – uniQure Set for Breakout Amid Promising Gene Therapy Advances
  5. Tony Fogleman on FTK – Flotek Poised for Breakout on Earnings Momentum

Recent Posts

  • IMDX – IMDX Set for Surge as FDA Decision Nears on GraftAssureDx
  • ADAP – Adaptimmune Set for Breakout with Pending FDA Approval UPDATE
  • ARTL – Artelo Poised for Breakout with Upcoming Clinical Trials
  • BFRI – Biofrontera Set for Breakout Amid Promising Clinical Trials
  • DRMA – Dermata Set for Breakout on Imminent FDA Approval and Strategic Partnerships

ScanScor empowers traders and investors with instant
AI-driven access to trusted intelligence.

🧠 Powered by real-time AI
🔍 Trained to find the moment before it moves

  • Terms and Conditions
  • About
  • Join the ScanScor Revolution

Disclaimer: ScanScor publishes research and educational content. Nothing here is investment advice or a solicitation to buy/sell securities. Past performance is not indicative of future results.

 

Copyright © 2025 EagleTrader ScanScor

Best viewed on desktop. Mobile optimization coming soon.

Scroll to Top